Terumo (TYO:4543) has decided to liquidate Terumo Capital Management, its wholly owned Singapore-based subsidiary, according to a Tokyo bourse filing on Friday.
The move is in line with the changes in the medical group's asset management structure.
Before the planned liquidation, the subsidiary has reduced its share capital to one share from about 1.1 billion shares.